Evidence map›Paper›PMID 23977142›Full record

ArticlePloS one2013

Effective Alu repeat based RT-Qpcr normalization in cancer cell perturbation experiments.

Ali Rihani, Tom Van Maerken, Filip Pattyn, Gert Van Peer, Anneleen Beckers, Sara De Brouwer, Candy Kumps, Evelien Mets, Joni Van der Meulen, Pieter Rondou and 4 more

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ali RihaniCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Tom Van Maerken
Filip Pattyn
Gert Van Peer
Anneleen Beckers
Sara De Brouwer
Candy Kumps
Evelien Mets
Joni Van der Meulen
Pieter Rondou
Carina Leonelli
Pieter Mestdagh
Frank Speleman
Jo Vandesompele

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMeasuring messenger RNA (mRNA) levels using the reverse transcription quantitative polymerase chain reaction (RT-qPCR) is common practice in many laboratories. A specific set of mRNAs as internal control reference genes is considered as the preferred strategy to normalize RT-qPCR data. Proper selection of reference genes is a critical issue, especially in cancer cells that are subjected to different in vitro manipulations. These manipulations may result in dramatic alterations in gene expression levels, even of assumed reference genes. In this study, we evaluated the expression levels of 11 commonly used reference genes as internal controls for normalization of 19 experiments that include neuroblastoma, T-ALL, melanoma, breast cancer, non small cell lung cancer (NSCL), acute myeloid leukemia (AML), prostate cancer, colorectal cancer, and cervical cancer cell lines subjected to various perturbations.

resultsThe geNorm algorithm in the software package qbase+ was used to rank the candidate reference genes according to their expression stability. We observed that the stability of most of the candidate reference genes varies greatly in perturbation experiments. Expressed Alu repeats show relatively stable expression regardless of experimental condition. These Alu repeats are ranked among the best reference assays in all perturbation experiments and display acceptable average expression stability values (M<0.5).

conclusionsWe propose the use of Alu repeats as a reference assay when performing cancer cell perturbation experiments.

Indexed as

Alu ElementsAngiogenesis InhibitorsCarrier ProteinsCell Line, TumorConserved SequenceGene Expression ProfilingGene Knockdown TechniquesHumansMicroRNAsProtein Kinase InhibitorsPyrimidinesReal-Time Polymerase Chain ReactionReference StandardsRepressor ProteinsReverse Transcriptase Polymerase Chain ReactionRNA, Small InterferingAngiogenesis InhibitorsCarrier ProteinsMicroRNAsNVP-TAE684PHF6 protein, humanProtein Kinase InhibitorsPyrimidinesRepressor ProteinsRNA, Small InterferingTretinoinwithaferin AWithanolides

Identifiers

PMID23977142
PMCPMC3743747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.